Deborah P M Symmons (D P M Symmons, Deborah P Symmons, Deborah Pm Symmons, Deborah Symmons)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2018
Publications (10 Years): 11

Top Topics

Radical Prostatectomy

Rheumatoid Arthritis

Smoking Cessation

Cardiovascular Disease

Top Venues

Annals of the rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Karen Minde Fagerli, Lianne Kearsley-Fleet, Kath D Watson, Jon Packham, Bsrbr-Ra Contributors Group, Deborah P M Symmons, Kimme L Hyrich
Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register. RMD open 4 (1) (2018)
James Martin Gwinnutt, Deborah P M Symmons, Alexander J MacGregor, Jacqueline R Chipping, Tarnya Marshall, Mark Lunt, Suzanne M M Verstappen
Have the 10-year outcomes of patients with early inflammatory arthritis improved in the new millennium compared with the decade before? Results from the Norfolk Arthritis Register. Annals of the rheumatic diseases 77 (6) (2018)
Meghna Jani, William G Dixon, Lianne Kersley-Fleet, Ian N Bruce, Hector Chinoy, Anne Barton, Mark Lunt, Kath Watson, null null, null null, Deborah P M Symmons, Kimme L Hyrich
Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. RMD open 3 (1) (2017)
Rebecca M Joseph, Mohammad Movahedi, William G Dixon, Deborah P M Symmons
Risks of smoking and benefits of smoking cessation on hospitalisations for cardiovascular events and respiratory infection in patients with rheumatoid arthritis: a retrospective cohort study using the Clinical Practice Research Datalink. RMD open 3 (2) (2017)
Audrey S L Low, Deborah P M Symmons, Mark Lunt, Louise K Mercer, Chris P Gale, Kath D Watson, William Gregory Dixon, Kimmie L Hyrich, null null
Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis. Annals of the rheumatic diseases 76 (4) (2017)
Lianne Kearsley-Fleet, Flora McErlane, Helen E Foster, Mark Lunt, Kath D Watson, Deborah P M Symmons, Kimme L Hyrich
Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis. RMD open 2 (2) (2016)
Louise K Mercer, James B Galloway, Mark Lunt, Rebecca Davies, Audrey L S Low, William Gregory Dixon, Kath D Watson, null null, Deborah P M Symmons, Kimmie L Hyrich
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Annals of the rheumatic diseases 76 (3) (2016)
R Agca, S C Heslinga, S Rollefstad, M Heslinga, I B McInnes, M J L Peters, T K Kvien, M Dougados, H Radner, F Atzeni, J Primdahl, A Södergren, S Wallberg Jonsson, J van Rompay, C Zabalan, T R Pedersen, L Jacobsson, K de Vlam, M A Gonzalez-Gay, A G Semb, G D Kitas, Y M Smulders, Z Szekanecz, N Sattar, Deborah P M Symmons, M T Nurmohamed
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Annals of the rheumatic diseases 76 (1) (2016)
J H Humphreys, Deborah P M Symmons, S M M Verstappen
Response to: 'Evaluation of the association between anticarbamylated protein antibodies and longitudinal course of functional ability in rheumatoid arthritis' by Ajeganova et al. Annals of the rheumatic diseases 75 (4) (2016)
Louise K Mercer, James B Galloway, Mark Lunt, Rebecca Davies, Audrey Al Low, William Gregory Dixon, Kath D Watson, Deborah P M Symmons, Kimmie L Hyrich
Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al. Annals of the rheumatic diseases 76 (2) (2016)
Kaleb D Michaud, Niklas Berglind, Stefan Franzén, Thomas Frisell, Christopher Garwood, Jeffrey D Greenberg, Meilien Ho, Marie Holmqvist, Laura Horne, Eisuke Inoue, Fredrik Nyberg, Dimitrios A Pappas, George Reed, Deborah P M Symmons, Eiichi Tanaka, Trung N Tran, Suzanne M M Verstappen, Eveline Wesby-van Swaay, Hisashi Yamanaka, Johan Askling
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease. Annals of the rheumatic diseases 75 (10) (2016)
Ibrahim Ibrahim, Jennifer Humphreys, Ibtisam Mokhtar, Tarnya Marshall, Suzanne Verstappen, Deborah P M Symmons, Sebastien Viatte, Anne Barton, Darren Plant
Association of chemokine CXC ligand 12 gene polymorphism (rs1746048) with cardiovascular mortality in patients with rheumatoid arthritis: results from the Norfolk Arthritis Register. Annals of the rheumatic diseases 74 (11) (2015)
Johan Askling, Niklas Berglind, Stefan Franzen, Thomas Frisell, Christopher Garwood, Jeffrey D Greenberg, Meilien Ho, Marie Holmqvist, Laura Horne, Eisuke Inoue, Kaleb D Michaud, Fredrik Nyberg, Dimitrios A Pappas, George Reed, Eiichi Tanaka, Trung N Tran, Suzanne M M Verstappen, Hisashi Yamanaka, Eveline Wesby-van Swaay, Deborah P M Symmons
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries. Annals of the rheumatic diseases 75 (10) (2015)